Suppr超能文献

MEKK2 激酶与 14-3-3 蛋白的结合调节 c-Jun N 端激酶的激活。

MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase.

机构信息

From the Department of Biology, York University, Toronto, Ontario M3J 1P3, Canada.

出版信息

J Biol Chem. 2013 Sep 27;288(39):28293-302. doi: 10.1074/jbc.M113.511352. Epub 2013 Aug 20.

Abstract

MEKK2 (MAP/ERK kinase kinase-2) is a serine/threonine kinase that belongs to the MEKK/STE11 family of MAP kinase kinase kinases (MAP(3)Ks). MEKK2 integrates stress and mitogenic signals to the activation of NF-κB, JNK1/2, p38, and ERK5 pathways. We have found that MEKK2 is regulated through a phosphorylation-dependent association with 14-3-3, a group of adapters that modulate dimerization and association between proteins. We found that MEKK2 was phosphorylated at Thr-283, which resulted in decreased activation loop phosphorylation at Ser-519 and consequently reduced activity. Mechanistically, we found that MEKK2 associated with inactive MEKK2 in the absence of 14-3-3 binding, which led to trans-autophosphorylation of Ser-519. Enforced binding with 14-3-3 reduced Ser-519 trans-autophosphorylation. Expression of T283A MEKK2 within a MEKK2(-/-) background enhanced stress-activated c-Jun N-terminal kinase activity while elevating IL-6 expression, but also reduced ERK activation with a corresponding reduced proliferation rate. These results indicate that Thr-283 phosphorylation is an important regulatory mechanism for MEKK2 activation.

摘要

MEKK2(丝氨酸/苏氨酸激酶激酶-2)是一种丝氨酸/苏氨酸激酶,属于 MAP 激酶激酶激酶(MAP3Ks)的 MEKK/STE11 家族。MEKK2 将应激和有丝分裂信号整合到 NF-κB、JNK1/2、p38 和 ERK5 途径的激活中。我们发现 MEKK2 通过与 14-3-3 的磷酸化依赖性关联来调节,14-3-3 是一组调节蛋白质二聚化和相互作用的接头蛋白。我们发现 MEKK2 在 Thr-283 处发生磷酸化,导致 Ser-519 激活环磷酸化减少,从而降低活性。从机制上讲,我们发现 MEKK2 在没有 14-3-3 结合的情况下与无活性的 MEKK2 结合,导致 Ser-519 的反式自磷酸化。与 14-3-3 的强制结合减少了 Ser-519 的反式自磷酸化。在 MEKK2(-/-)背景下表达 T283A MEKK2 增强了应激激活的 c-Jun N 端激酶活性,同时提高了 IL-6 的表达,但也降低了 ERK 的激活,相应地降低了增殖率。这些结果表明 Thr-283 磷酸化是 MEKK2 激活的重要调节机制。

相似文献

1
MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase.
J Biol Chem. 2013 Sep 27;288(39):28293-302. doi: 10.1074/jbc.M113.511352. Epub 2013 Aug 20.
3
6
MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
Eur J Immunol. 2003 Oct;33(10):2903-9. doi: 10.1002/eji.200324127.
7
MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression.
J Biol Chem. 2001 May 4;276(18):14784-90. doi: 10.1074/jbc.M010134200. Epub 2001 Feb 6.
8
Dimerization through the catalytic domain is essential for MEKK2 activation.
J Biol Chem. 2005 Apr 8;280(14):13477-82. doi: 10.1074/jbc.M414258200. Epub 2005 Feb 4.
9
Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells.
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4599-604. doi: 10.1073/pnas.081021898. Epub 2001 Mar 27.
10
Mip1, an MEKK2-interacting protein, controls MEKK2 dimerization and activation.
Mol Cell Biol. 2005 Jul;25(14):5955-64. doi: 10.1128/MCB.25.14.5955-5964.2005.

引用本文的文献

1
2
14-3-3β Depletion Drives a Senescence Program in Glioblastoma Cells Through the ERK/SKP2/p27 Pathway.
Mol Neurobiol. 2018 Feb;55(2):1259-1270. doi: 10.1007/s12035-017-0407-8. Epub 2017 Jan 23.
3
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.
Microbiol Mol Biol Rev. 2016 Jul 27;80(3):793-835. doi: 10.1128/MMBR.00043-14. Print 2016 Sep.
5
The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14284-9. doi: 10.1073/pnas.1510495112. Epub 2015 Nov 4.
6
Dynamic self-guiding analysis of Alzheimer's disease.
Oncotarget. 2015 Jun 10;6(16):14092-122. doi: 10.18632/oncotarget.4221.
7
Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeutics.
Oncotarget. 2015 Jun 10;6(16):14522-36. doi: 10.18632/oncotarget.3995.
8
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.
Nature. 2014 Jun 12;510(7504):283-7. doi: 10.1038/nature13320. Epub 2014 May 21.
9
MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells.
Biochim Biophys Acta. 2014 May;1843(5):945-54. doi: 10.1016/j.bbamcr.2014.01.029. Epub 2014 Jan 31.

本文引用的文献

1
Phosphorylation of MEKK3 at threonine 294 promotes 14-3-3 association to inhibit nuclear factor kappaB activation.
J Biol Chem. 2008 May 9;283(19):13261-8. doi: 10.1074/jbc.M801474200. Epub 2008 Feb 28.
2
A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling.
Nature. 2006 Nov 9;444(7116):230-4. doi: 10.1038/nature05280. Epub 2006 Nov 1.
3
TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent.
J Biol Chem. 2006 Jul 28;281(30):21013-21021. doi: 10.1074/jbc.M512908200. Epub 2006 May 31.
4
PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation.
Mol Cell Biol. 2006 Mar;26(6):2065-79. doi: 10.1128/MCB.26.6.2065-2079.2006.
5
Phosphorylation of serine 526 is required for MEKK3 activity, and association with 14-3-3 blocks dephosphorylation.
J Biol Chem. 2006 Mar 10;281(10):6236-45. doi: 10.1074/jbc.M509249200. Epub 2006 Jan 9.
6
Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways.
EMBO J. 2006 Jan 11;25(1):97-107. doi: 10.1038/sj.emboj.7600913. Epub 2005 Dec 15.
7
Mip1, an MEKK2-interacting protein, controls MEKK2 dimerization and activation.
Mol Cell Biol. 2005 Jul;25(14):5955-64. doi: 10.1128/MCB.25.14.5955-5964.2005.
8
Dimerization through the catalytic domain is essential for MEKK2 activation.
J Biol Chem. 2005 Apr 8;280(14):13477-82. doi: 10.1074/jbc.M414258200. Epub 2005 Feb 4.
10
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
Nat Immunol. 2004 Jan;5(1):98-103. doi: 10.1038/ni1014. Epub 2003 Dec 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验